While COVID appears to be on a downward trend across much of the globe, including the U.S., there continue to be hotspots and surges, particularly
COVID continues to make news in the U.S. and around the world. With the XBB.1.5 variant now the dominant strain in the U.S., there is
It may be a new year, but influenza, RSV, and COVID cases are all continuing to have an impact as we move into 2023. Currently
Rates of respiratory diseases typically tend to increase this time of year, but this year’s increase is anything but typical. Not only are we seeing
Key Points: COVID In today’s Recommendation for Industry, we discuss the overall positive trajectory of COVID cases, even with variants continuing to emerge. Read more
Key Points: COVID In today’s Recommendation for Industry, we discuss norovirus cases. Read more below. Updated COVID booster tied to strong Omicron immune response. The
Key Points: COVID In today’s Recommendation for Industry, we discuss what it means to be up to date in COVID vaccinations. Read more below. CDC
Key Points: COVID In today’s Recommendation for Industry, we discuss the continued trend of Monkeypox and Covid. Read more below. Regular physical activity tied to
Key Points: In today’s Recommendation for Industry, we discuss the continuing evolution of COVID vaccines. Read more below. Feds look ahead to next-generation COVID vaccines.
Key Points: In today’s Recommendation for Industry, we discuss how COVID cases are rising. Read more below. CDC panel recommends Novavax vaccine as BA.5 gains
